BIT Capital’s Oric Pharmaceuticals ORIC Stock Holding History

BIT Capital’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-108,624	Closed	-$1.49M	–	123
2024 Q1	$1.49M	Buy	+108,624	New	+$1.29M	0.11%	75

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT Capital's ORIC Position: Q2 2024 in Review

BIT Capital sold out of Oric Pharmaceuticals (ORIC) in Q2 2024, closing a stake of 108,624 shares — an estimated $1.49M sold.

BIT Capital first reported a position in ORIC in Q1 2024 and held it in 1 quarter. The position peaked at $1.49M in Q1 2024. 113 funds tracked by Wall St. Rank hold ORIC as of Q2 2024.

BIT Capital reported no remaining Oric Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
BIT Capital sold 108,624 Oric Pharmaceuticals shares in Q2 2024, an estimated $1.49M.
BIT Capital first reported a position in Oric Pharmaceuticals in Q1 2024 and held it in 1 quarter.
BIT Capital's Oric Pharmaceuticals position peaked at $1.49M in Q1 2024.
113 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2024.

Based on BIT Capital's 13F filing for Q2 2024, filed 12 Feb 2025.